New Market Report: Singapore Pharmaceuticals & Healthcare Report Q1 2014
The island state's consistent investment in research and development, coupled with the government's increased commitment to healthcare, will provide pharmaceutical firms opportunities -especially in light of the ageing population. Nevertheless we highlight that Singapore's small population will continue to limit the pharmaceutical market's long-term growth potential.
View full press release